Product
Supplier
Encyclopedia
Inquiry
Aticaprant Aticaprant buy - large image1
Aticaprant Aticaprant buy - image1
Aticaprant Aticaprant buy - image2
Aticaprant Aticaprant buy - image3

Aticaprant Aticaprant

GMP ISO TDS 21 Inquiries

Unit Price: Get Latest Price
CAS No.:

1174130-61-0

Grade:

Pharmaceutical Grade

Content:

99.75%

Port:

c

Brand:

Million

Packaging:

1g 10g 100g 1kg/bag 25kg/Cardboard Drum

Price valid (until):

2025-03-08

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

  • Product Description

  • Seller Information

  • Inquiry History

  • Description



    Shop Apixaban CAS 503612-47-3 high quality best service fast delivery large stock manufacturer-Detailed Image 2


    Why Choose Us 

    1 、 Manufacturer supply, best price and service.

    2、 Safe fast delivery.

    3、 F ree sample.

    4、 Large stock.

    5、 Easy payment: bank transfer,  moneygram, paypal....

    6、 Good reputation, great feedback.

    7、 Customers worldwide:  Metrochem Api Pvt Ltd;Bdr Lifesciences Pvt.Ltd;Srini Chem;Eva Pharma;Pharmaffiliates Analytics&Synthetics(p)Ltd;....From India,Egypt,Canada ....


    -Packing&Shipping-

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 3


    Ship methods
    Special line
    Express By air
    By sea
    DHL/TNT/FeDex/UPS
    Delivery 7-15 days 3-10 days 3-5 days 10-30 days
    Service Door to door Door to door To airport To seaport
    Customs clearance No Possible Yes Yes

    -Company Profile-

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 4

    Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 5


    About us:

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
       Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixab a n, Lurasidon e , Bexagliflozin, Vortioxetine, L OXO -292/Selpercatinib, Baricitinib and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...


    Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
     
       The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
     
       Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.


    -Certification- Shop Apixaban intermediates 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS 536760-29-9-Detailed Image 6

    Certificates
    • Aticaprant Aticaprant Certificates 3

    Basic Info
    Product Name:

    4-[4-[[(2S)-2-(3,5-Dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluorobenzamide

    CAS No.:

    1174130-61-0

    Molecular Formula:

    C26H27FN2O2

    InChIKeys:

    InChIKey=ZHPMYDSXGRRERG-DEOSSOPVSA-N

    Exact Mass:

    418.50

    Characteristics
  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

    Location:

    Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China

    Payment Terms:

    L/C,100% TT in advance

    Average lead Time:

    3

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2012

    Certifications:

    business license

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
    Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixaban, Lurasidone, Bexagliflozin, Votioxitine, Loxo-292/Selpercatinib, Baricitinib and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; INCETPAT PHARM; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...



    Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
     
    The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
     
    Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.

  • Inquiry History
    21 Inquiries
    Country Product Purchase Quantity Date Posted
    Poland

    LY2456302 Aticaprant CAS 1174130-61-0

    2 G Feb 22, 2026
    United States

    Aticaprant Cas No. 1174130-61-0

    1 G Feb 13, 2026
    United Kingdom

    Aticaprant LY-2456302 LY2456302 CAS 1174130-61-0

    1 G Jan 14, 2026
    United States

    CERC-501(LY-2456302,Aticaprant)

    1.0 G Jun 16, 2026
    United States

    Aticaprant

    1 MT Jan 28, 2026
    United States

    Aticaprant

    1 MT Jan 4, 2026
    Slovakia

    Aticaprant

    1 G Dec 26, 2025
    United States

    Aticaprant

    1 G Dec 26, 2025
    Poland

    aticaprant

    1 G Mar 30, 2026
    China

    LY-2456302,Aticaprant

    100 MG Mar 6, 2026
    Canada

    Aticaprant

    1 G Mar 5, 2026
    China

    Aticaprant

    1 G Mar 4, 2026
    Brazil

    Aticaprant

    1 G Feb 25, 2026
    Poland

    Aticaprant

    10 G Feb 22, 2026
    United States

    4-[4-[[(2S)-2-(3,5-Dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluorobenzamide

    1 G Feb 19, 2026
    United States

    Aticaprant

    50 G May 12, 2026
    Switzerland

    Aticaprant

    1 G Apr 10, 2026
    United States

    Aticaprant

    1 G Mar 4, 2026
    United States

    Aticaprant

    1 G Feb 23, 2026
    Italy

    Aticaprant

    1 G Jan 29, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.